SpaceX Starship avoids explosive fate of last 2 launches, but still suffers demise midflight
ORLANDO, Fla. — SpaceX managed to send its developmental Starship back into space surpassing the explosive fates that befell its last two attempts, while also for the first time flying with a reused Super Heavy booster. But not everything went well with the upper stage, which lost control during its suborbital trip halfway around the Earth.
The massive combined rocket and spacecraft began its the ninth suborbital test flight well, lifting off from the company's Texas site Starbase at 7:37 p.m. Eastern time.
'It's one hell of sight from here,' said SpaceX commentator Dan Huot. 'We see it arcing right over top of us, we see 33 out of 33 Raptor engines lit on Super Heavy as it starts to ascend skyward.'
'That was incredible. We could feel the building shaking here, feel the vehicle's power,' added SpaceX's Jessie Anderson.
The booster's reuse was mostly successful having previously flown in January. Unlike its last trip, SpaceX was not attempting a recovery back at the launch site, and the booster broke apart shortly before its attempted splashdown over the Gulf waters off the coast of Texas.
But it did successfully send the Starship upper stage on its way into suborbital space, improving on the January and March attempts this year that both ended with the upper stage disintegrating soon after launch leaving trails of debris visible from South Florida and the Caribbean.
While the investigation into the March flight's demise is ongoing, the Federal Aviation Administration last week gave SpaceX the OK to go with was the third Starship launch of the year and ninth suborbital test flight overall.
But there was no storybook ending for this mission, as SpaceX lost contact with Starship somewhere over the Indian Ocean so it never made it to the planned splashdown site off the western coast of Australia.
SpaceX hit its first snag with the upper stage when it failed a payload door test that was supposed to let the company deploy some Starlink satellite simulators using what commentators called its PEZ dispenser.
The door didn't open all the way, so SpaceX opted to close it and continue on with its prime objective, which was to survive reentry, part of its eventual effort to have the Starship upper stage to return safely to the launch site.
About 30 minutes into the flight, though, Huot revealed Starship had suffered some sort of leak in its fuel tank systems causing it to be in 'in a little bit of a spin' and that prompted the company to skip another planned test of relighting of one of its Raptor engines midflight.
'At this point, we've essentially lost our attitude control with Starship. We are still on a path toward reentry. We are suborbital, so no matter what we are going to enter, however, this lowers the chances for it to be a controlled reentry,' he said. 'So not looking great with a lot of our on-orbit objectives for today. We were hoping to do the PEZ deploy and relight an engine, and then, really importantly, get into that controlled entry to really put the heat shield through the ringer.'
Without any control, SpaceX opted to dump all of the spacecraft's remaining fuel. In the end, the company lost contact with Starship about 45 minutes into flight.
'We're continuing to learn more about this ship, about this rocket,' Huot said. 'We are trying to do something that is impossibly hard, and it's not always going to — you're not going to reach it in a straight line. We said there's going to be bumps, there's going to be turns, but seeing that ship in space today was a hell of a moment for us.'
To date all launches have been from Texas, but the company is building out two launch sites on the Space Coast.
At more than 400 feet tall and the booster producing more than 16 million pounds of thrust at liftoff, Starship is the biggest and most powerful rocket that has made it to space, although it has yet to perform an orbital launch.
NASA has a vested interest in the system getting completed as a version of Starship has been tapped to be the human landing system for the Artemis III mission that seeks to return humans to the moon for the first time since the end of the Apollo program in 1972.
Despite the partial failure of flight 9, the FAA this year increased SpaceX's license so it can fly up to 25 missions a year out of Texas.
'This is exactly the SpaceX way,' Anderson said. 'We're going to learn, iterate and iterate over and over again until we figure it out.'
-----------
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Exclusive-After Trump feud, role of Musk's SpaceX in Golden Dome missile shield in question
By Marisa Taylor and Nandita Bose WASHINGTON (Reuters) -The role of Elon Musk's SpaceX in an ambitious new U.S. missile defense system is in question following the dramatic feud last week between the billionaire entrepreneur and President Donald Trump, according to three people familiar with the project. The White House until recently had considered a plan for SpaceX, Musk's rocket and satellite venture, to partner with software maker Palantir and drone builder Anduril to construct crucial elements of the project, dubbed "Golden Dome." The administration had instructed the Pentagon to prioritize a network of satellites for the purpose, these people said. But a new framework for the system, which would seek to track and prevent possible missile attacks against the United States, is now being considered that could reduce the role of SpaceX. One possibility, the three people said, could initially forego SpaceX's satellite capabilities and focus on the expansion of existing ground systems for missile defense instead. In a statement, a White House spokesman said "the Trump Administration is committed to a rigorous review process for all bids and contracts." A senior Defense Department official said the Pentagon "has no announcements regarding future contracts associated with the Golden Dome effort." SpaceX, Anduril and Palantir didn't respond to requests for comment. A reduced role for SpaceX would represent the first known setback to Musk's huge volume of business with the U.S. government since his break with Trump last week. The shift in plans, especially for a project that Trump has touted as paramount for U.S. defense strategy, also underscores the highly personalized nature of the president's leadership, aerospace and defense experts said. "That people guiding the program or building it are approved based on their political affiliation signals a real concern that the project itself is very politicized and not being conducted on the technical merits," said Laura Grego, a missile defense expert and research director at the Union of Concerned Scientists, a non-profit based in Cambridge, Massachusetts. In its statement to Reuters, the White House said any decision would be made "prioritizing the best deal for America and leveraging the most advanced and innovative technology." Trump in May said the defense shield should be operational by the end of his presidency, January 2029. But industry experts have said that timeframe, and a projected cost of some $175 billion, could be too optimistic. The change in the proposed "architecture" of the system, the three people said, could have the political advantage of allowing the current administration to deliver at least a portion of it. It isn't clear how soon a final decision on the project could come or whether the ultimate role of any company, including SpaceX, has been determined. Trump's efforts to roll out the project fast have led to uncertainty about the project's details and a scramble by contractors to be involved, industry experts and some of those involved in its development told Reuters. "To this day, no one knows what the requirements are," said one of the people familiar with the process. "There isn't a coordinated effort with a true vision. All of these companies are just grabbing at this pot of money." SpaceX, Anduril and Palantir were all founded by entrepreneurs who have been major political supporters of Trump. The three companies had previously met with top administration officials and decisionmakers from the Defense Department to discuss Golden Dome, according to people familiar with those discussions. Before his high-profile falling out with the president, Musk served as a key Trump advisor and donated more than a quarter of a billion dollars to help elect him. But the recent dispute, which included Musk calling for Trump's impeachment and accusing the president of improper involvement with disgraced financier and sex offender Jeffrey Epstein, triggered the change in direction, the three people told Reuters. "Because of the blowup, the Pentagon has been given the space to look at other alternatives," one of the people said. In recent days, Musk has sought to temper the dispute, saying he regretted some of his comments and taking down some of his social media criticism of Trump, including the call for impeachment. Earlier this week, Press Secretary Karoline Leavitt told reporters that Trump appreciated Musk's apology and that she was unaware of any administration efforts to review Musk contracts because of the dispute. Reuters couldn't determine whether Musk's conciliatory overtures might improve SpaceX's chances of winning Golden Dome contracts or securing further new business with the U.S. government. SpaceX had pitched for a part of the Golden Dome initiative called the "custody layer," a constellation of between 400 and 1,000 satellites that would detect missiles, track their trajectory, and determine if they are heading toward the U.S., Reuters reported in April. In a January 27 executive order, Trump mandated the selection of a proposed "architecture" for Golden Dome and an implementation plan by the end of March. The order called a missile attack "the most catastrophic threat facing the United States." (Additional reporting by Mike Stone and Idrees Ali. Editing by Chris Sanders and Paulo Prada.) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 minutes ago
- Yahoo
Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders
Meeting to Reconvene on Wednesday, July 9, 2025 SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today announced that the company's 2025 annual meeting of stockholders (the 'Annual Meeting') was convened and adjourned without any business conducted due to lack of the required quorum. A quorum is necessary to hold the Annual Meeting. There were fewer than a majority of shares entitled to vote present, either in person or by proxy, at the Annual Meeting. The Annual Meeting therefore had no quorum and was adjourned to allow time to solicit additional proxies on behalf of the company's board of directors. The Annual Meeting will reconvene at 9:00 a.m. Pacific Time on Wednesday, July 9, 2025, and will continue to be held virtually. Stockholders who have already submitted a proxy or voted do not need to vote again, as proxies and votes previously submitted in respect of the Annual Meeting will remain valid at the reconvened Annual Meeting unless properly revoked. The record date for determining stockholders eligible to vote at the reconvened Annual Meeting remains April 17, 2025. Stockholders as of close of business on the April 17, 2025 record date who have not yet voted are encouraged to vote online at or by telephone at 1-800-690-6903. Please vote by 11:59 p.m. Eastern Time on July 8, 2025. If you hold your shares of the company's common stock in an account at a brokerage firm, bank, dealer or other similar organization, you may be subject to an earlier voting deadline and you should carefully review any materials received from the organization holding those shares regarding how to vote to ensure your vote is counted. A copy of the company's definitive proxy statement for the Annual Meeting is available to stockholders on on the Company's website at and on the website maintained by the U.S. Securities and Exchange Commission ('SEC') at Daré Bioscience stockholders as of close of business on the April 17, 2025 record date for the Annual Meeting, or their legal proxy holders, will be able to attend the reconvened Annual Meeting by visiting Important Information This material may be deemed to be solicitation material in respect of the Annual Meeting to be reconvened and held on Wednesday, July 9, 2025. In connection with the Annual Meeting, the company filed a definitive proxy statement with the SEC on April 24, 2025. BEFORE MAKING ANY VOTING DECISION, THE COMPANY URGES ITS STOCKHOLDERS TO READ THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING. The definitive proxy statement was sent or made available to stockholders entitled to vote at the Annual Meeting on or about April 24, 2025. No changes have been made to the proposals to be voted on by stockholders at the Annual Meeting. A copy of the definitive proxy statement and any other materials filed by the company with the SEC can be obtained free of charge at the SEC's website at or the company's website at About Daré Bioscience Daré Bioscience is a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority. Daré believes that innovation does not have to start from scratch. The company's goal is to bring to market as soon as practicable innovative evidence-based solutions that address decades of unmet needs in women's health and enhance outcomes and convenience, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. The potential products Daré identifies, in many cases, already have clinical proof of concept or existing safety data for the active ingredient that the company leverages. This provides optionality and flexibility, in many cases, in how Daré seeks to bring solutions to market in ways designed to optimize access for women in a fiscally responsible manner. The first FDA-approved product to emerge from Daré's portfolio of women's health product candidates is XACIATO™ (clindamycin phosphate) vaginal gel 2%, a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older, which is under a global license agreement with Organon. Visit for information about XACIATO. Daré's portfolio also includes potential first-in-category candidates in clinical development: Ovaprene®, a novel, hormone-free monthly intravaginal contraceptive whose U.S. commercial rights are under a license agreement with Bayer; Sildenafil Cream, 3.6%, a novel cream formulation of sildenafil citrate, the active ingredient in an oral erectile dysfunction drug for men, to treat female sexual arousal disorder (FSAD); and DARE-HRT1, a combination bio-identical estradiol and progesterone intravaginal ring for menopausal hormone therapy. To learn more about Daré's full portfolio of women's health product candidates and mission to deliver differentiated therapies for women, please visit Daré Bioscience leadership has been named on the Medicine Maker's Power List and Endpoints News' Women in Biopharma and Daré's CEO has been honored as one of Fierce Pharma's Most Influential People in Biopharma for Daré's contributions to innovation and advocacy in the women's health space. Daré may announce material information about its finances, product and product candidates, clinical trials and other matters using the Investors section of its website ( SEC filings, press releases, public conference calls and webcasts. Daré will use these channels to distribute material information about the company and may also use social media to communicate important information about the company, its finances, product and product candidates, clinical trials and other matters. The information Daré posts on its investor relations website or through social media channels may be deemed to be material information. Daré encourages investors, the media, and others interested in the company to review the information Daré posts in the Investors section of its website and to follow these X (formerly Twitter) accounts: @SabrinaDareCEO and @DareBioscience. Any updates to the list of social media channels the company may use to communicate information will be posted in the Investors section of Daré's website. Contacts: Daré Bioscience Investor Relationsinnovations@ Source: Daré Bioscience, in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
Impeachment? Deportation? Crazy? 6 takeaways from the wild feud between Trump and Elon Musk
WASHINGTON – Elon Musk, who led a scorched-earth strategy in recommending the dismantling of federal agencies and laying off tens of thousands of workers, continued burning bridges after leaving his special White House job advising President Donald Trump. Musk's lobbying days before the blowup to kill Trump's centerpiece tax bill spurred the president to voice his disappointment June 5. Trump later said on social media his adviser 'just went CRAZY!' Trump threatened to cancel billions in federal contracts with Musk's companies. Meanwhile, Musk endorsed a third Trump impeachment. Not satisfied with predicting Trump's tariffs would lead to a recession, Musk later accused Trump of consorting with accused sex trafficker Jeffrey Epstein. Trump's political adviser and former White House aide Steve Bannon suggested the president should deport Musk back to his native South Africa. Here are six takeaways about the feud and where it might lead: Musk has called the cost of Trump's legislative package of tax and spending cuts a 'disgusting abomination,' and urged lawmakers to kill it. Trump responded during an Oval Office meeting with German Chancellor Friedrich Merz by saying he was disappointed with Musk. Trump blamed Musk's criticism on the legislation aiming to end incentives for electric vehicles, which Musk's company Tesla manufactures, and for discarding his choice to head the National Aeronautics and Space Administration, which works with Musk's SpaceX rockets. "I'm very disappointed with Elon," Trump said. 'I can understand why he's upset." "Elon and I had a great relationship," Trump added later. "I don't know if we will anymore." When someone else suggested on social media that Trump should be impeached and replaced by Vice President JD Vance, Musk replied, 'Yes.' The House impeached Trump during his first term. Once was for his urging Ukraine's President Volodymyr Zelenskyy to investigate his Democratic rival, Joe Biden. The second time was for inciting the riot Jan. 6, 2021, at the Capitol. The Senate acquitted Trump both times after failing to get a two-thirds majority for conviction. Musk upped the ante by predicting Trump's tariffs – the centerpiece of his economic policy – would cause a recession. 'The Trump tariffs will cause a recession in the second half of this year,' Musk wrote on social media. Trump has argued the tariffs would bring the government billions in revenue and force manufacturers to bring jobs back to the U.S. He has also used tariffs as leverage to negotiate trade deals with other countries. Jeffrey Epstein was a financier charged federally with sex trafficking. He died by suicide in a New York jail cell in August 2019. Conspiracy theorists have speculated that powerful people silenced Epstein rather than have their secrets exposed. Trump and Epstein were filmed and photographed together at parties. In 2002 Trump praised the wealthy businessman as a "terrific guy' but he has since distanced himself from him. Attorney General Pam Bondi said she would declassify the government's files on Epstein but about 200 pages released Feb. 27 implicated no one else. "Time to drop the really big bomb," Musk said in a June 5 post on X. "@realDonaldTrump is in the Epstein files. That is the real reason they have not been made public. Have a nice day, DJT!" The White House responded that Musk was unhappy with Trump's legislative package. 'This is an unfortunate episode from Elon, who is unhappy with the One Big Beautiful Bill because it does not include the policies he wanted,' White House press secretary Karoline Leavitt said. 'The President is focused on passing this historic piece of legislation and making our country great again.' Trump later threatened on social media to cancel Musk's government contracts and subsidies. "The easiest way to save money in our Budget, Billions and Billions of Dollars, is to terminate Elon's Governmental Subsidies and Contracts," Trump said. "I was always surprised that Biden didn't do it!" Tesla's shares dropped 14%, losing about $150 billion in market share, on June 5. Trump's legislative package seeks to end government subsidies for electric vehicles. Musk's SpaceX also relies on billions in contracts to transport people and supplies to the International Space Station. The government must rely on private rockets or the rockets of other countries for such trips after retiring the space shuttle program. 'In light of the President's statement about cancellation of my government contracts, @SpaceX will begin decommissioning its Dragon spacecraft immediately,' Musk wrote. One of Trump's informal advisers, Steve Bannon, told the New York Times he was urging the president to launch several investigations into Musk, including whether he should be deported. Musk came to the U.S. on a student visa and has since become a naturalized citizen, but critics have raised questions about whether Musk overstayed the terms of his original visa. 'They should initiate a formal investigation of his immigration status, because I am of the strong belief that he is an illegal alien, and he should be deported from the country immediately,' Bannon said. This article originally appeared on USA TODAY: 6 takeaways from Trump and Musk's ruptured relationship and wild feud